JUVÉDERM® VOLUX® XC is an injectable gel designed to improve jawline definition in patients with moderate to severe loss of volume in the lower face. It is specifically tailored to add volume along the jawline area, providing smooth, long-lasting definition in the jawline for adults over 21 years of age.
The effects of JUVÉDERM® VOLUX® XC can last up to 1 year with optimal treatment. The most common side effects were temporary reactions at the treatment site, such as tenderness, lumps/bumps, pain, swelling, firmness, bruising, redness, and itching. Most of the side effects were mild or moderate in nature and generally resolved in 2-4 weeks.
JUVÉDERM® VOLUX® XC is a specially formulated injectable gel aimed at patients with significant jawline definition loss. Its dense consistency allows precise modeling, adding volume to the lower face and reshaping the structure to create a well-defined, chiseled chin. JUVÉDERM® VOLUX® XC is versatile in its ability to address various aesthetic concerns, ranging from subtle corrections to more dramatic results. The treatment results can last up to 1 year with optimal treatment.
If you are looking to stock up on JUVEDERM® VOLUX XC fillers, we offer easy access and competitive pricing to meet all your practice's needs. Elevate your service offerings and patient satisfaction now by placing your order today.
JUVÉDERM® VOLUX® XC is an injectable gel designed to improve jawline definition in patients with moderate to severe loss of volume in the lower face. The gel is injected in small amounts into the treatment area until the desired aesthetic outcome is achieved. The treatment may involve gentle massage of the treatment area to ensure even integration of the product into the skin. Ice may be applied for a brief period following treatment to minimize swelling and reduce pain. The lidocaine in the gel helps to reduce injection site pain.
We pride ourselves on fast, efficient delivery, ensuring your products arrive when you need them, so you can continue providing uninterrupted care.
Medical practices today face increasing patient demands for skin rejuvenation treatments that deliver natural-looking results with minimal downtime. Your patients are seeking solutions that address skin quality concerns beyond what traditional fillers offer. They want treatments that enhance overall skin health rather than just targeting specific wrinkles.
Many medical professionals struggle to find injectable treatments that effectively address skin hydration and smoothness without creating an over-filled appearance. This challenge leaves practices with limited options to meet the growing demand for subtle, natural-looking skin quality improvements.
SKINVIVE™ by JUVÉDERM® changes this dynamic by offering something truly innovative in the aesthetic marketplace. As the first and only FDA-approved hyaluronic acid microdroplet injectable in the US designed specifically for improving cheek skin smoothness and hydration, SKINVIVE™ by JUVÉDERM® fills a critical gap in treatment options.
For medical practices, integrating SKINVIVE™ by JUVÉDERM® into your service offerings addresses several key practice challenges:
SKINVIVE™ by JUVÉDERM® represents a significant advancement in hyaluronic acid technology. Unlike traditional dermal fillers that add volume beneath the skin, SKINVIVE™ by JUVÉDERM® works through a unique microdroplet delivery system that specifically targets the dermis to improve overall skin quality.
The proprietary formula in SKINVIVE™ by JUVÉDERM® is designed to increase hydration and improve skin smoothness through intradermal injection to improve facial skin quality. The injectable gel uses hyaluronic acid, a naturally occurring substance in the skin that helps maintain hydration. When precisely injected into the superficial dermis, these microdroplets work to:
This innovative approach addresses a fundamental need in aesthetic treatment – improving skin quality without changing facial structure or creating an artificial appearance.
The effectiveness of SKINVIVE™ by JUVÉDERM® lies in its specialized formulation and delivery method. The injectable gel contains hyaluronic acid in a concentration specifically optimized for intradermal placement. When properly injected in microdroplets, the treatment creates a network of hydration points that:
Clinical studies demonstrate that SKINVIVE™ by JUVÉDERM® treatment leads to measurable improvements in skin hydration, smoothness, and overall appearance. Patients treated with SKINVIVE™ reported high satisfaction with how glowing and healthy their skin looked months after treatment.
SKINVIVE™ by JUVÉDERM® represents a new category of injectable treatments that complements rather than replaces traditional fillers. Understanding this distinction helps medical practices position the treatment correctly:
SKINVIVE™ by JUVÉDERM® |
Traditional Dermal Fillers |
Improves skin quality |
Adds volume |
Enhances hydration and smoothness |
Fills wrinkles and folds |
Intradermal injection (superficial dermis) |
Typically deeper placement |
Distributed in microdroplets |
Usually placed in lines or bolus |
Creates overall skin improvement |
Targets specific areas |
Natural-looking enhancement |
Can create more dramatic changes |
Minimal downtime |
Variable downtime |
This clear differentiation allows medical practices to recommend the appropriate treatment based on patient concerns and desired outcomes.
Incorporating SKINVIVE™ by JUVÉDERM® into your treatment offerings provides several significant advantages for medical practices:
Understanding which patients are candidates for SKINVIVE™ by JUVÉDERM® helps medical practices properly position this innovative treatment. SKINVIVE™ by JUVÉDERM® is most appropriate for patients who:
The versatility of SKINVIVE™ by JUVÉDERM® makes it suitable for various Fitzpatrick skin types and a wide age range of patients, from those seeking preventative care to those addressing established skin quality concerns.
Medical practices can confidently set accurate expectations for the SKINVIVE™ by JUVÉDERM® treatment process:
Patients typically require minimal downtime, with most able to return to normal activities immediately. As with all injectable treatments, patients should avoid strenuous exercise, excessive sun or heat exposure, and alcoholic beverages shortly after treatment to minimize potential side effects.
For medical practices to maximize the benefits of SKINVIVE™ by JUVÉDERM®, proper technique and patient management are essential:
SKINVIVE™ by JUVÉDERM® leverages the natural properties of hyaluronic acid in a formulation specifically designed for intradermal application. This specialized approach allows for:
The hyaluronic acid in SKINVIVE™ by JUVÉDERM® is precisely formulated to integrate with the skin’s structure while providing the hydration benefits that improve overall skin quality.
The FDA approval of SKINVIVE™ by JUVÉDERM® is based on robust clinical studies demonstrating its safety and effectiveness. Key clinical findings include:
These clinical outcomes provide medical practices with confidence in recommending SKINVIVE™ by JUVÉDERM® for appropriate patients.
When discussing SKINVIVE™ by JUVÉDERM® with patients, medical professionals should review important safety considerations:
Medical practices can effectively incorporate SKINVIVE™ by JUVÉDERM® by positioning it as:
By clearly defining SKINVIVE™ by JUVÉDERM®’s place in your treatment offerings, patients can better understand its benefits and appropriate applications.
Successful implementation of SKINVIVE™ by JUVÉDERM® in a medical practice requires:
Effectively communicating the benefits of SKINVIVE™ by JUVÉDERM® to patients involves:
When patients fully understand what SKINVIVE™ by JUVÉDERM® can achieve, satisfaction rates improve and expectations are appropriately managed.
Medical practices implementing SKINVIVE™ by JUVÉDERM® report consistent patient satisfaction with results including:
These outcomes align with the clinical findings and support the value proposition of SKINVIVE™ by JUVÉDERM® as a unique skin quality improvement option.
Medical practices have found SKINVIVE™ by JUVÉDERM® particularly beneficial for:
By identifying these ideal candidates within your patient base, practices can effectively target their SKINVIVE™ by JUVÉDERM® marketing efforts.
Medical practices can prepare to address common patient questions about SKINVIVE™ by JUVÉDERM®:
How is SKINVIVE™ by JUVÉDERM® different from other JUVÉDERM® products? SKINVIVE™ by JUVÉDERM® is specifically formulated for intradermal injection to improve facial skin quality, rather than adding volume like traditional fillers. It uses microdroplet technology to enhance skin hydration and smoothness.
How long do SKINVIVE™ by JUVÉDERM® results last? Clinical studies show results can last up to 6 months with optimal treatment, though individual results may vary based on factors like skin condition, age, and lifestyle.
Is there downtime after SKINVIVE™ by JUVÉDERM® treatment? Most patients experience minimal downtime with temporary injection site reactions like redness, swelling, or bruising that typically resolve within a few days.
Can SKINVIVE™ by JUVÉDERM® be combined with other treatments? Yes, SKINVIVE™ by JUVÉDERM® complements other aesthetic treatments like BOTOX® Cosmetic, traditional fillers, and energy-based devices for comprehensive rejuvenation.
How many treatments are needed for optimal results? Initial treatment protocols typically involve a single session, with maintenance treatments recommended approximately every 6 months based on individual response.
SKINVIVE™ by JUVÉDERM® represents a significant innovation in the aesthetic marketplace for several key reasons:
For medical practices seeking to expand their treatment offerings with innovative, effective options, SKINVIVE™ by JUVÉDERM® provides a unique advantage.
Medical practices ready to incorporate SKINVIVE™ by JUVÉDERM® can follow these steps:
By following a structured implementation approach, medical practices can successfully incorporate SKINVIVE™ by JUVÉDERM® and maximize its benefits for both the practice and patients.
As medical practices continue to evolve their aesthetic offerings, SKINVIVE™ by JUVÉDERM® represents an important advancement in addressing patient concerns about skin quality. This innovative treatment aligns with current trends toward:
By embracing SKINVIVE™ by JUVÉDERM® as part of a modern aesthetic practice, medical professionals position themselves at the forefront of skin quality treatment innovation.
Discover how Pipeline Medical’s marketplace can streamline your practice’s procurement process for SKINVIVE™ by JUVÉDERM® and other premium aesthetic products, ensuring you have reliable access to the innovative treatments your patients demand.
The information provided on this site is for informational purposes only and is not intended to substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider or medical professional for guidance on any medical concerns, product use, or treatment decisions.
If you have more questions, our sales team is ready to assist you. Reach out to our customer service team for personalized support and answers to all your inquiries.